Biologics, with their precision targeting, expand treatment options for a multitude of diseases - from cancer to autoimmune disorders. In 2023 alone, 10 antibody therapeutics received their first ...
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
The novel, end-to-end automated workflow introduces a new method of choice for single-shot mass spectrometry plasma analysis without fractionation The bead-based plasma depletion technology ...
Historically, the drug development process can take 10-15 years from the initial discovery phase to regulatory approval. Moreover, the total cost of these endeavors can often run into billions of ...
The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry.Deep ...
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...
Headlamp Health has launched Lumos AI®, a new decision-support platform designed to bring greater precision to neuroscience ...
Learn all about the drivers and challenges of single-cell sequencing with this White Paper and Preview Video by 10x Genomics on accelerating drug discovery with an automated single cell workflow.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback